What 8 Analyst Ratings Have To Say About Amrize
Across the recent three months, 8 analysts have shared their insights on Amrize (NYSE:AMRZ), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 3 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 1 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 1 | 1 | 1 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $60.38, along with a high estimate of $67.00 and a low estimate of $53.00. This current average has increased by 4.63% from the previous average price target of $57.71.
Investigating Analyst Ratings: An Elaborate Study
In examining recent analyst actions, we gain insights into how financial experts perceive Amrize. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Timna Tanners | Wells Fargo | Raises | Overweight | $59.00 | $58.00 |
| Bryan Blair | Oppenheimer | Raises | Outperform | $64.00 | $62.00 |
| Anthony Pettinari | Citigroup | Raises | Buy | $67.00 | $63.00 |
| Marcus Cole | UBS | Raises | Neutral | $57.00 | $53.00 |
| Anthony Codling | RBC Capital | Raises | Sector Perform | $60.00 | $56.00 |
| Trey Grooms | Stephens & Co. | Announces | Overweight | $60.00 | - |
| Marcus Cole | UBS | Raises | Neutral | $53.00 | $52.00 |
| Anthony Pettinari | Citigroup | Raises | Buy | $63.00 | $60.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Amrize. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Amrize compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Amrize's stock. This analysis reveals shifts in analysts' expectations over time.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Amrize's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on Amrize analyst ratings.
Unveiling the Story Behind Amrize
Amrize is a building solutions company focused exclusively on the North American market. Amrize earns revenue from the sale of cement, aggregates, ready-mix concrete, asphalt, roofing systems, and other building solutions. The company is organized into two reportable segments: building materials and building envelope. The building materials business consists of Amrize's cement, aggregates, ready-mix concrete, and asphalt operations. The building envelope segment offers advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings, along with adhesives, tapes, and sealants.
Amrize: A Financial Overview
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Over the 3M period, Amrize showcased positive performance, achieving a revenue growth rate of 6.65% as of 30 September, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Amrize's net margin is impressive, surpassing industry averages. With a net margin of 14.83%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Amrize's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 4.3%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Amrize's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 2.28%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Amrize's debt-to-equity ratio is below the industry average at 0.53, reflecting a lower dependency on debt financing and a more conservative financial approach.
The Basics of Analyst Ratings
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.